CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company
Phio Pharmaceuticals Corp.
Sign in to watch- Ticker
- PHIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453215903
- Phone
- (508) 767-3861
- Business address
- 411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
- Former names
- RXi Pharmaceuticals Corp
- Open-market buys, last 90 days
- $45,755
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$45,755. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Deming David H Director | Purchase | +5,200 | $0.84 | $4K | 49,800 |
| 2026-11-10 | Deming David H Director | Purchase | +6,800 | $0.84 | $6K | 44,600 |
| 2026-11-09 | Plott Ronald Todd Director | Purchase | +18,300 | $0.83 | $15K | 60,300 |
| 2026-11-09 | Bitterman Robert J Chairman, Pres. & CEO | Purchase | +25,000 | $0.82 | $21K | 789,871 |
Page 1 of 1 · 4 trades